Journal article

Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers

Logan C Walker, Nic Waddell, Anette Ten Haaf, Sean Grimmond, Amanda B Spurdle

Breast Cancer Research and Treatment | SPRINGER | Published : 2008

University of Melbourne Researchers


Awarded by NHMRC

Funding Acknowledgements

We thank Sue Healey for providing assistance with BIC nomenclature and classifications, and David Hunter and Jonathan Beesley for helpful comments. We would like to thank all the Australian Red Cross Blood Services donors who participated as healthy controls in this study, Rachelle Morris and the staff at the Australian Red Cross Blood Services for their assistance with the collection of risk factor information and blood samples, and Helene Holland for data management, Mary-Anne Kedda, Joanne Young, Melanie Higgins, Kimberly Hinze, Robert Smith, Judith Clements, Melissa Barker, Rebecca Magson, Genevieve Birney and other members of the Molecular Cancer Epidemiology Laboratory, for their assistance with collection and processing of Australian Red Cross Blood Services blood samples. We thank Denis Moss for access to LCLs from controls recruited through the QIMR. We also wish to thank Heather Thorne, Eveline Niedermayr, Jan Groves, Amber Williams, the kConFab mutation review committee, kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics, and the Clinical Follow Up Study (funded by NHMRC grants 145684 and 288704) for their contributions to this resource, and the many families who contribute to kConFab. kConFab is supported by grants from the National Breast Cancer Foundation, the National Health and Medical Research Council (NHMRC) and by the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. This research was supported by a grant from the Susan G. Komen Breast Cancer Foundation, and the NHMRC. LCW was supported by funding from NHMRC, NW was supported by funding from the National Breast Cancer Foundation, SMG is an NMHRC Senior Research Fellow, and ABS is a recipient of an NHMRC Career Development Award.